Ji Hyun Lee
Seul National University Bundang Hospital · Seoul National University Hospital · Magenta Therapeutics
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ji Hyun Lee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:32 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07774689 · AI-ECG for Preoperative Cardiovascular Risk Stratification Before General SurgerySeoul National University Bundang Hospital · not yet recruiting · Perioperative Cardiovascular Risk, Postoperative Complications (Cardiopulmonary), Preoperative Care · principal investigator
- N/ANCT05906225 · Anesthesia and EEG Discontinuity in InfantsSeoul National University Hospital · unknown · Anesthesia, General, Electroencephalography, Infant · principal investigator
- Ph2NCT05445128 · Study of MGTA-145 and Plerixafor in Patients With Sickle Cell DiseaseEnsoma · terminated · Sickle Cell Disease · study director
- N/ANCT04482166 · Learning Curve of Fiberoptic Intubation Through Supraglottic Airway DeviceSeoul National University Hospital · completed · Intubation;Difficult · principal investigator
- N/ANCT04364945 · Association Between Anesthetic Drugs for General Anesthesia and Postoperative Intelligence/behavioral Assessment Results in ChildrenSeoul National University Hospital · active not recruiting · Anesthesia and Neurotoxicity · principal investigator
- Ph4NCT03914404 · Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic NeuropathyChonbuk National University Hospital · completed · Diabetic Neuropathy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 128 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Peripheral Artery DiseaseR41HL170875 · NHLBI · SERINA THERAPEUTICS, INC. · fiscal years 2023 · $340,956 awarded in 2023Same name and institution; not confirmed by an ID
- Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating StrokeR41NS105263 · NINDS · SERINA THERAPEUTICS, INC. · fiscal years 2018 · $385,923 awarded in 2018Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:32 UTC. The ranking covers the 200 most relevant of 1427 PubMed records, and a shared surname and initials can bring in a namesake. All 1427 on PubMed
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.N Engl J Med · 20191,106 citationsRCR 41.3
- Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.N Engl J Med · 2021491 citationsRCR 33.1
- Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.J Am Coll Cardiol · 2018456 citationsRCR 21.3
- 322 citationsRCR 19.6
- 320 citationsRCR 12.8
- 235 citationsRCR 15.5
- 130 citationsRCR 9.2
- AI Improves Nodule Detection on Chest Radiographs in a Health Screening Population: A Randomized Controlled Trial.Radiology · 2023112 citationsRCR 11.5
- 110 citationsRCR 4.2
- 110 citationsRCR 15.9